| Year |
Citation |
Score |
| 2020 |
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, ... ... Pezawas L, et al. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D receptor agonist radioligand study. Translational Psychiatry. 10: 2. PMID 32066718 DOI: 10.1038/S41398-019-0681-5 |
0.412 |
|
| 2019 |
Meyer BM, Rabl U, Huemer J, Bartova L, Kalcher K, Provenzano J, Brandner C, Sezen P, Kasper S, Schatzberg AF, Moser E, Chen G, Pezawas L. Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study. Translational Psychiatry. 9: 64. PMID 30718459 DOI: 10.1038/s41398-019-0395-8 |
0.6 |
|
| 2018 |
Pilger A, Haslacher H, Meyer BM, Lackner A, Nassan-Agha S, Nistler S, Stangelmaier C, Endler G, Mikulits A, Priemer I, Ratzinger F, Ponocny-Seliger E, Wohlschläger-Krenn E, Teufelhart M, Täuber H, ... ... Pezawas L, et al. Midday and nadir salivary cortisol appear superior to cortisol awakening response in burnout assessment and monitoring. Scientific Reports. 8: 9151. PMID 29904183 DOI: 10.1038/s41598-018-27386-1 |
0.322 |
|
| 2016 |
Rabl U, Provenzano J, Meyer B, Bartova L, Ortner N, Sezen P, Moser E, Kasper S, Pezawas L. Effects of antidepressant treatment with escitalopram on hippocampal structure and connectivity − a longitudinal study European Neuropsychopharmacology. 26: S379. DOI: 10.1016/S0924-977X(16)31327-X |
0.411 |
|
| 2015 |
Haslacher H, Michlmayr M, Batmyagmar D, Perkmann T, Ponocny-Seliger E, Scheichenberger V, Scherzer TM, Nistler S, Pilger A, Dal-Bianco P, Lehrner J, Pezawas L, Wagner OF, Winker R. rs6295 [C]-Allele Protects Against Depressive Mood in Elderly Endurance Athletes. Journal of Sport & Exercise Psychology. 37: 637-45. PMID 26866771 DOI: 10.1123/jsep.2015-0111 |
0.343 |
|
| 2015 |
Pezawas L. Serotonin Transporter Linked Polymorphic Region: From Behavior to Neural Mechanisms. Biological Psychiatry. 78: 522-4. PMID 26386626 DOI: 10.1016/j.biopsych.2015.08.010 |
0.391 |
|
| 2015 |
Haslacher H, Michlmayr M, Batmyagmar D, Perkmann T, Ponocny-Seliger E, Scheichenberger V, Pilger A, Dal-Bianco P, Lehrner J, Pezawas L, Wagner O, Winker R. Physical exercise counteracts genetic susceptibility to depression. Neuropsychobiology. 71: 168-75. PMID 25998702 DOI: 10.1159/000381350 |
0.381 |
|
| 2015 |
Bartova L, Meyer BM, Diers K, Rabl U, Scharinger C, Popovic A, Pail G, Kalcher K, Boubela RN, Huemer J, Mandorfer D, Windischberger C, Sitte HH, Kasper S, Praschak-Rieder N, ... ... Pezawas L, et al. Reduced default mode network suppression during a working memory task in remitted major depression. Journal of Psychiatric Research. 64: 9-18. PMID 25801734 DOI: 10.1016/J.Jpsychires.2015.02.025 |
0.487 |
|
| 2014 |
Meyer BM, Huemer J, Rabl U, Boubela RN, Kalcher K, Berger A, Banaschewski T, Barker G, Bokde A, Büchel C, Conrod P, Desrivières S, Flor H, Frouin V, Gallinat J, ... ... Pezawas L, et al. Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults. Brain Structure & Function. PMID 25319752 DOI: 10.1007/S00429-014-0895-5 |
0.446 |
|
| 2014 |
Rabl U, Meyer BM, Diers K, Bartova L, Berger A, Mandorfer D, Popovic A, Scharinger C, Huemer J, Kalcher K, Pail G, Haslacher H, Perkmann T, Windischberger C, Brocke B, ... ... Pezawas L, et al. Additive gene-environment effects on hippocampal structure in healthy humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9917-26. PMID 25057194 DOI: 10.1523/Jneurosci.3113-13.2014 |
0.622 |
|
| 2014 |
Michl J, Scharinger C, Zauner M, Kasper S, Freissmuth M, Sitte HH, Ecker GF, Pezawas L. A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinities. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1463-74. PMID 25044049 DOI: 10.1016/J.Euroneuro.2014.06.013 |
0.405 |
|
| 2014 |
Scharinger C, Rabl U, Kasess CH, Meyer BM, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, ... ... Pezawas L, et al. Platelet serotonin transporter function predicts default-mode network activity. Plos One. 9: e92543. PMID 24667541 DOI: 10.1371/Journal.Pone.0092543 |
0.532 |
|
| 2014 |
Kuhn M, Popovic A, Pezawas L. Neuroplasticity and memory formation in major depressive disorder: an imaging genetics perspective on serotonin and BDNF. Restorative Neurology and Neuroscience. 32: 25-49. PMID 23603442 DOI: 10.3233/Rnn-139005 |
0.768 |
|
| 2013 |
Popovic A, Kuhn M, Pezawas L. Chronic pain from a psychiatric perspective: Neurobiology and therapy | Chronische Schmerzen aus psychiatrischer Sicht: Neurobiologie und Therapie Manuelle Medizin. 51: 47-52. DOI: 10.1007/S00337-012-1006-4 |
0.718 |
|
| 2012 |
Kalcher K, Huf W, Boubela RN, Filzmoser P, Pezawas L, Biswal B, Kasper S, Moser E, Windischberger C. Fully exploratory network independent component analysis of the 1000 functional connectomes database. Frontiers in Human Neuroscience. 6: 301. PMID 23133413 DOI: 10.3389/Fnhum.2012.00301 |
0.39 |
|
| 2012 |
Boubela RN, Huf W, Kalcher K, Sladky R, Filzmoser P, Pezawas L, Kasper S, Windischberger C, Moser E. A highly parallelized framework for computationally intensive MR data analysis. Magma (New York, N.Y.). 25: 313-20. PMID 22086306 DOI: 10.1007/S10334-011-0290-7 |
0.357 |
|
| 2011 |
Scharinger C, Bartova L, Pezawas L. Brain-derived neurotrophic factor: a peripheral biomarker for major depressive disorder and antidepressant efficacy? Personalized Medicine. 8: 115-117. PMID 29783402 DOI: 10.2217/pme.11.9 |
0.35 |
|
| 2011 |
Scharinger C, Rabl U, Pezawas L, Kasper S. The genetic blueprint of major depressive disorder: contributions of imaging genetics studies. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 474-88. PMID 21830992 DOI: 10.3109/15622975.2011.596220 |
0.483 |
|
| 2011 |
Huf W, Kalcher K, Pail G, Boubela R, Pezawas L, Windischberger C, Moser E, Friedrich ME, Filzmoser P, Kasper S. P.2.c.020 Synthesising evidence in clinical psychopharmacology and beyond: a re-examination of published meta-analyses European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70634-4 |
0.37 |
|
| 2011 |
Kalcher K, Pail G, Huf W, Scharinger C, Boubela R, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. S.07.04 Alterations of functional connectivity between basal ganglia and cortical regions during resting-state in remitted major depressive disorder European Neuropsychopharmacology. 21: S196. DOI: 10.1016/S0924-977X(11)70265-6 |
0.472 |
|
| 2011 |
Kalcher K, Pail G, Huf W, Scharinger C, Boubela R, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. P.3.016 Increased functional coupling between basal ganglia and cortical regions during resting state in remitted major depressive disorder European Neuropsychopharmacology. 21: S71-S72. DOI: 10.1016/S0924-977X(11)70084-0 |
0.468 |
|
| 2011 |
Scharinger C, Kasess C, Huf W, Kalcher K, Esterbauer H, Moser E, Sitte H, Kasper S, Pezawas L. P.1.033 Serotonin uptake in platelets predicts neural activation in the cingulate cortex European Neuropsychopharmacology. 21: S27. DOI: 10.1016/S0924-977X(11)70032-3 |
0.412 |
|
| 2011 |
Pail G, Scharinger C, Kalcher K, Huf W, Boubela R, Hartinger B, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. Remitted major depression is related to increased functional coupling between ventral striatum and cortical regions in resting state fMRI European Psychiatry. 26: 948-948. DOI: 10.1016/S0924-9338(11)72653-0 |
0.49 |
|
| 2011 |
Kalcher K, Pail G, Huf W, Scharinger C, Boubela R, Hartinger B, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. Increased coupling of resting state activity between amygdala and cortical emotion processing regions in remitted major depressive disorder European Psychiatry. 26: 931-931. DOI: 10.1016/S0924-9338(11)72636-0 |
0.495 |
|
| 2011 |
Fink M, Moser U, Pezawas L, Savli M, Stein P, Hahn A, Spindelegger C, Wadsak W, Windischberger C, Mitterhauser M, Kasper S, Lanzenberger R. Multimodal imaging of an astrocytoma affecting the amygdalar region European Psychiatry. 26: 924-924. DOI: 10.1016/S0924-9338(11)72629-3 |
0.475 |
|
| 2011 |
Boubela R, Kalcher K, Pail G, Huf W, Scharinger C, Hartinger B, Windischberger C, Filzmoser P, Moser E, Kasper S, Pezawas L. Increased functional coupling between basalganglia and cingulate and prefrontal cortex during resting state conditions in remitted major depressive disorder European Psychiatry. 26: 915-915. DOI: 10.1016/S0924-9338(11)72620-7 |
0.487 |
|
| 2011 |
Scharinger C, Kasess C, Huf W, Kalcher K, Esterbauer H, Sitte H, Kasper S, Moser E, Pezawas L. P02-89 - Peripheral serotonin uptake is related to neural activation in the cingulate cortex European Psychiatry. 26: 684-684. DOI: 10.1016/S0924-9338(11)72390-2 |
0.464 |
|
| 2011 |
Hartinger B, Scharinger C, Diers K, Kasess C, Huf W, Kalcher K, Boubela R, Pail G, Brocke B, Kasper S, Moser E, Pezawas L. P02-38 - Biological alterations during remission of major depressive disorder European Psychiatry. 26: 633-633. DOI: 10.1016/S0924-9338(11)72339-2 |
0.525 |
|
| 2010 |
Rabl U, Scharinger C, Müller M, Pezawas L. Imaging genetics: implications for research on variable antidepressant drug response. Expert Review of Clinical Pharmacology. 3: 471-89. PMID 22111678 DOI: 10.1586/ecp.10.35 |
0.307 |
|
| 2010 |
Bartova L, Berger A, Pezawas L. Is there a personalized medicine for mood disorders? European Archives of Psychiatry and Clinical Neuroscience. 260: S121-6. PMID 20957381 DOI: 10.1007/s00406-010-0152-8 |
0.322 |
|
| 2010 |
Pezawas L, Meyer-Lindenberg A. Imaging genetics: Progressing by leaps and bounds. Neuroimage. 53: 801-3. PMID 20816317 DOI: 10.1016/j.neuroimage.2010.08.001 |
0.411 |
|
| 2010 |
Scharinger C, Rabl U, Sitte HH, Pezawas L. Imaging genetics of mood disorders. Neuroimage. 53: 810-21. PMID 20156570 DOI: 10.1016/J.Neuroimage.2010.02.019 |
0.365 |
|
| 2010 |
Kasess C, Scharinger C, Pail G, Uzelac Z, Freissmuth M, Kasper S, Moser E, Sitte H, Pezawas L. P.2.b.025 Serotonin uptake in blood platelets is related to cingulate cortex activation European Neuropsychopharmacology. 20: S367. DOI: 10.1016/S0924-977X(10)70515-0 |
0.393 |
|
| 2010 |
Huf W, Pail G, Hartinger B, Kasess C, Kasper S, Mattay V, Meyer-Lindenberg A, Moser E, Weinberger D, Pezawas L. P.1.e.015 Emotion cognition interaction located using surface-based versus volume-based analysis European Neuropsychopharmacology. 20: S296-S297. DOI: 10.1016/S0924-977X(10)70394-1 |
0.623 |
|
| 2010 |
Pail G, Huf W, Kasess C, Kasper S, Moser E, Brocke B, Meyer-Lindenberg A, Mattay V, Weinberger D, Pezawas L. P.1.e.011 Fronto-limbic interaction of working memory and emotion in the medial prefrontal cortex European Neuropsychopharmacology. 20: S294. DOI: 10.1016/S0924-977X(10)70390-4 |
0.641 |
|
| 2009 |
Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Chen Q, Weinberger DR, Meyer-Lindenberg A. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Archives of General Psychiatry. 66: 467-77. PMID 19414706 DOI: 10.1001/archgenpsychiatry.2009.24 |
0.704 |
|
| 2009 |
Honea R, Verchinski BA, Pezawas L, Kolachana BS, Callicott JH, Mattay VS, Weinberger DR, Meyer-Lindenberg A. Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage. 45: 44-51. PMID 19071221 DOI: 10.1016/j.neuroimage.2008.10.064 |
0.78 |
|
| 2009 |
Spindelegger C, Lanzenberger R, Wadsak W, Mien LK, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Molecular Psychiatry. 14: 1040-50. PMID 18362913 DOI: 10.1038/mp.2008.35 |
0.414 |
|
| 2009 |
Pezawas L, Meyer-Lindenberg A, Goldman A, Verchinski B, Chen G, Kolachana B, Egan M, Mattay V, Hariri A, Weinberger D. Epistasis of BDNF and SLC6A4 impact Brain Structure in Depression Neuroimage. 47: S161-S162. DOI: 10.1016/S1053-8119(09)71706-9 |
0.699 |
|
| 2009 |
Pail G, Huf W, Kasses C, Goldman A, Moser E, Chen G, Meyer-Lindenberg A, Mattay V, Pezawas L, Weinberger. Impact of Emotion on Working Memory Network Recruitment Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71352-7 |
0.58 |
|
| 2009 |
Pezawas L. S.28.04 Serotonin transporter gene polymorphism and susceptibility to depression European Neuropsychopharmacology. 19: S216-S217. DOI: 10.1016/S0924-977X(09)70302-5 |
0.332 |
|
| 2008 |
Zanardi R, Barbini B, Rossini D, Bernasconi A, Fregni F, Padberg F, Rossi S, Wirz-Justice A, Terman M, Martiny K, Bersani G, Hariri AR, Pezawas L, Roiser JP, Bertolino A, et al. New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging. Psychiatry and Clinical Neurosciences. 62: 627-37. PMID 19067998 DOI: 10.1111/J.1440-1819.2008.01863.X |
0.535 |
|
| 2008 |
Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Molecular Psychiatry. 13: 709-16. PMID 18347599 DOI: 10.1038/mp.2008.32 |
0.769 |
|
| 2008 |
Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Zoltick B, Weinberger DR, Meyer-Lindenberg A. Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Biological Psychiatry. 63: 475-83. PMID 17727823 DOI: 10.1016/j.biopsych.2007.06.006 |
0.724 |
|
| 2008 |
Honea RA, Meyer-Lindenberg A, Hobbs KB, Pezawas L, Mattay VS, Egan MF, Verchinski B, Passingham RE, Weinberger DR, Callicott JH. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biological Psychiatry. 63: 465-74. PMID 17689500 DOI: 10.1016/j.biopsych.2007.05.027 |
0.752 |
|
| 2008 |
Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. MET BDNF protects against morphological S allele effects of 5-HTTLPR Molecular Psychiatry. 13: 654. DOI: 10.1038/mp.2008.61 |
0.712 |
|
| 2008 |
Pezawas L. BDNF X SERT interactions: Implication for depression International Journal of Psychophysiology. 69: 190. DOI: 10.1016/J.IJPSYCHO.2008.05.510 |
0.317 |
|
| 2007 |
Angst J, Gamma A, Pezawas L, Ajdacic-Gross V, Eich D, Rössler W, Altamura C. Parsing the clinical phenotype of depression: the need to integrate brief depressive episodes. Acta Psychiatrica Scandinavica. 115: 221-8. PMID 17302622 DOI: 10.1111/j.1600-0447.2006.00893.x |
0.347 |
|
| 2007 |
Buckholtz JW, Meyer-Lindenberg A, Honea RA, Straub RE, Pezawas L, Egan MF, Vakkalanka R, Kolachana B, Verchinski BA, Sust S, Mattay VS, Weinberger DR, Callicott JH. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1584-93. PMID 17301167 DOI: 10.1523/JNEUROSCI.5112-06.2007 |
0.778 |
|
| 2006 |
Meyer-Lindenberg A, Buckholtz JW, Kolachana B, R Hariri A, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proceedings of the National Academy of Sciences of the United States of America. 103: 6269-74. PMID 16569698 DOI: 10.1073/pnas.0511311103 |
0.767 |
|
| 2005 |
Pezawas L, Angst J, Kasper S. Recurrent brief depression revisited. International Review of Psychiatry (Abingdon, England). 17: 63-70. PMID 16194772 DOI: 10.1080/00207390500064650 |
0.467 |
|
| 2005 |
Winkler D, Pjrek E, Praschak-Rieder N, Willeit M, Pezawas L, Konstantinidis A, Stastny J, Kasper S. Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biological Psychiatry. 58: 331-6. PMID 16102546 DOI: 10.1016/j.biopsych.2005.01.031 |
0.407 |
|
| 2005 |
Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, Hariri AR, Verchinski BA, Meyer-Lindenberg A, Balkissoon R, Kolachana B, Goldberg TE, Weinberger DR. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 102: 8627-32. PMID 15939883 DOI: 10.1073/pnas.0500515102 |
0.747 |
|
| 2005 |
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience. 8: 828-34. PMID 15880108 DOI: 10.1038/Nn1463 |
0.761 |
|
| 2005 |
Kasper S, Pezawas L. Will atypical antipsychotics play a role in phase prophylaxis? Pharmacopsychiatry. 38. DOI: 10.1055/s-2005-918732 |
0.35 |
|
| 2004 |
Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10099-102. PMID 15537879 DOI: 10.1523/JNEUROSCI.2680-04.2004 |
0.717 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Presslich O, Tauscher J, Kasper S. Relationship between power spectra of the awake EEG and psychomotor activity patterns measured by short-term actigraphy. Neuropsychobiology. 48: 176-81. PMID 14673214 DOI: 10.1159/000074634 |
0.374 |
|
| 2003 |
Pezawas L, Wittchen HU, Pfister H, Angst J, Lieb R, Kasper S. Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults. Psychological Medicine. 33: 407-18. PMID 12701662 DOI: 10.1017/S0033291702006967 |
0.447 |
|
| 2003 |
Pezawas L, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Recurrent brief depression--past and future. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 75-83. PMID 12551729 DOI: 10.1016/S0278-5846(02)00318-4 |
0.354 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Presslich O, Tauscher J, Kasper S, Lai I, Hong C, Tsai S, Huo S, Yen F, Tung C, Pan G, Watanabe M, Harada S, et al. Contents Vol. 48, 2003 Neuropsychobiology. 48: 221-222. DOI: 10.1159/000075624 |
0.319 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Presslich O, Tauscher J, Kasper S, Lai I, Hong C, Tsai S, Huo S, Yen F, Tung C, Pan G, Watanabe M, Harada S, et al. Subject Index Vol. 48, 2003 Neuropsychobiology. 48: 219-220. DOI: 10.1159/000075623 |
0.356 |
|
| 2003 |
Winkler D, Pjrek E, Pezawas L, Konstantinidis A, Presslich O, Tauscher J, Kasper S. P.6.060 Influence of psychopharmacologic treatment on short-term actigraphic measurements European Neuropsychopharmacology. 13: S451. DOI: 10.1016/S0924-977X(03)92358-3 |
0.363 |
|
| 2002 |
Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, et al. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 3: 133-46. PMID 12478878 DOI: 10.3109/15622970209150614 |
0.499 |
|
| 2002 |
Pezawas L, Stamenkovic M, Jagsch R, Ackerl S, Putz C, Stelzer B, Moffat RR, Schindler S, Aschauer H, Kasper S. A longitudinal view of triggers and thresholds of suicidal behavior in depression. The Journal of Clinical Psychiatry. 63: 866-73. PMID 12416595 DOI: 10.4088/Jcp.V63N1003 |
0.411 |
|
| 2002 |
Pezawas L, Stamenkovic M, Aschauer N, Moffat R, Kasper S. Successful treatment of recurrent brief depression with reboxetine -- a single case analysis. Pharmacopsychiatry. 35: 75-6. PMID 11951149 DOI: 10.1055/s-2002-25023 |
0.348 |
|
| 2002 |
Pezawas L, Fischer G, Podreka I, Schindler S, Brücke T, Jagsch R, Thurnher M, Kasper S. Opioid addiction changes cerebral blood flow symmetry. Neuropsychobiology. 45: 67-73. PMID 11893862 DOI: 10.1159/000048679 |
0.394 |
|
| 2001 |
Stamenkovic M, Blasbichier T, Riederer F, Pezawas L, Brandstätter N, Aschauer HN, Kasper S. Fluoxetine treatment in patients with recurrent brief depression. International Clinical Psychopharmacology. 16: 221-6. PMID 11459336 |
0.381 |
|
| 2001 |
Pezawas L, Stamenkovic M, Kasper S. [Recurrent brief depressive episodes. Epidemiology, clinical aspects, diagnosis and therapy]. Der Nervenarzt. 72: 169-80. PMID 11268761 DOI: 10.1007/s001150050736 |
0.459 |
|
| 2000 |
Pezawas L, Quiner S, Moertl D, Tauscher J, Barnas C, Küfferle B, Wolf R, Kasper S. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance. International Clinical Psychopharmacology. 15: 207-14. PMID 10954060 |
0.326 |
|
| 2000 |
Pezawas L, Stamenkovic M, Jagsch R, Ackerl S, Putz C, Stelzer B, Aschauer H, Kasper S. Suicidal behavior in patients with recurrent brief depression (RBD) European Neuropsychopharmacology. 10: 274. DOI: 10.1016/S0924-977X(00)80268-0 |
0.418 |
|
| 2000 |
Stamenkovic M, Blasbichler T, Brandstätter N, Pezawas L, Aschauer H, Kasper S. 308. Fluoxetine treatment in patients with recurrent brief depression (RBD) Biological Psychiatry. 47: S93. DOI: 10.1016/S0006-3223(00)00572-2 |
0.439 |
|
| 1999 |
Kasper S, Tauscher J, Küfferle B, Barnas C, Pezawas L, Quiner S. Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 249: 83-9. PMID 10654113 DOI: 10.1007/Pl00014189 |
0.451 |
|
| 1999 |
Kasper S, Pezawas L. [Depression and anxiety]. Wiener Medizinische Wochenschrift (1946). 149: 494-502. PMID 10637953 |
0.342 |
|
| 1999 |
Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger G, Pezawas L, Aschauer HN, Kasper S. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction (Abingdon, England). 94: 1337-47. PMID 10615719 DOI: 10.1046/J.1360-0443.1999.94913376.X |
0.381 |
|
| 1999 |
Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol. Psychopharmacology. 141: 175-81. PMID 9952042 DOI: 10.1007/s002130050822 |
0.385 |
|
| 1999 |
Pezawas L, Stamenkovic M, Ackerl S, Putz C, Stelzer B, Blasbichler T, Schindler S, Aschauer H, Kasper S. Clinical characteristics of patients with recurrent brief depression (RBD) European Neuropsychopharmacology. 9: 245. DOI: 10.1016/S0924-977X(99)80221-1 |
0.433 |
|
| 1998 |
Stamenkovic M, Pezawas L, de Zwaan M, Aschauer HN, Kasper S. Mirtazapine in recurrent brief depression. International Clinical Psychopharmacology. 13: 39-40. PMID 9988366 DOI: 10.1097/00004850-199801000-00006 |
0.456 |
|
| 1998 |
Pezawas LM, Fischer G, Diamant K, Schneider C, Schindler SD, Thurnher M, Ploechl W, Eder H, Kasper S. Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements. Psychiatry Research. 83: 139-47. PMID 9849723 DOI: 10.1016/S0925-4927(98)00028-6 |
0.334 |
|
| 1998 |
Bailer U, Praschak-Rieder N, Pezawas L, Kasper S. [Mirtazapine in inpatient treatment of depressed patients]. Wiener Klinische Wochenschrift. 110: 646-50. PMID 9816638 |
0.37 |
|
| 1998 |
Pezawas L, Quiner S, Tauscher J, Kuefferle B, Barnas C, Wolf R, Kasper S. Sertindole in clinical practice European Neuropsychopharmacology. 8: S236. DOI: 10.1016/S0924-977X(98)80407-0 |
0.331 |
|
| 1998 |
Tauscher J, Küfferle B, Barnas C, Pezawas L, Asenbaum S, Tauscher-Wisniewski S, Brücke T, Kasper S. Correlation of striatal dopamine-2 receptor occupancy and extrapyramidal side-effects during antipsychotic treatment: A 1231IBZM 3PECT study European Neuropsychopharmacology. 8: S230-S231. DOI: 10.1016/S0924-977X(98)80390-8 |
0.374 |
|
| 1997 |
Pezawas L, Fischer G, Diamant K, Schneider C, Podreka I, Brücke T, Thurnher M, Kasper S. Brain perfusion is abnormal during opioid dependence: SPECT imaging with Tc-99m-HMPAO Psychiatry Research: Neuroimaging. 68: 173. DOI: 10.1016/S0925-4927(97)81562-4 |
0.381 |
|
| 1997 |
Fischer G, Gombas W, Eder H, Jagsch R, Schindler SD, Pezawas L, Kasper S. P.5.036 Comparison of buprenorphine and methadone in opiate addicts European Neuropsychopharmacology. 7. DOI: 10.1016/S0924-977X(97)88869-4 |
0.365 |
|
| 1997 |
Pezawas L, Küfferle B, Barnas C, Wolf R, Kasper S. P.2.083 Sertindole in clinical practice European Neuropsychopharmacology. 7: S218. DOI: 10.1016/S0924-977X(97)88717-2 |
0.352 |
|
| 1997 |
Stamenkovic M, Pezawas L, Aschauer H, de Zwaan M, Kasper S. P.1.162 Mirtazapine in recurrent brief depression (RBD) European Neuropsychopharmacology. 7: S186-S187. DOI: 10.1016/S0924-977X(97)88611-7 |
0.434 |
|
| 1997 |
Kasper S, Tauscher J, Pezawas L, Barnas C, Küfferle B, Aschauer H. S.18.03 Efficacy of new antipsychotics in negative symptoms European Neuropsychopharmacology. 7: S114. DOI: 10.1016/S0924-977X(97)88419-2 |
0.372 |
|
| 1997 |
Pezawas L, Küfferle B, Kasper S. Nimodipine in a lithium non-responder with bipolar I disorder Biological Psychiatry. 42: 251S. DOI: 10.1016/S0006-3223(97)87955-3 |
0.44 |
|
| 1997 |
Stamenkovic M, Pezawas L, Aschauer H, de Zwaan M, Kasper S. Mirtazapine in recurrent brief depression (RBD) Biological Psychiatry. 42: 242S. DOI: 10.1016/S0006-3223(97)87906-1 |
0.428 |
|
| 1997 |
Pezawas L, Fischer G, Schindler S, Diamant K, Plöchl W, Eder H, Thumher M, Kasper S. Computed tomography of the brain in opioid dependence Biological Psychiatry. 42: 66S. DOI: 10.1016/S0006-3223(97)87149-1 |
0.369 |
|
| 1996 |
Fischer G, Diamant K, Pezawas L, Schindler S, Podreka I, Kasper S. Abnormal regional cerebral blood flow in opioid dependent patients European Neuropsychopharmacology. 6: S4-129. DOI: 10.1016/0924-977X(96)83179-8 |
0.367 |
|
| 1996 |
Schindler S, Pezawas L, Fischer G, Diamant K, Schneider C, Forster G, Eder H, Podreka I, Kasper S. Changes in brain perfusion during opioid dependence: SPECT imaging with Tc-99m-HMPAO European Psychiatry. 11: 329s. DOI: 10.1016/0924-9338(96)89029-8 |
0.378 |
|
| 1995 |
Fischer G, Diamant K, Schneider C, Pezawas L, Presslich O, Frey R, Kapitany T, Kasper S. P-10-31 Gammahydroxy butyric acid (GHB) for detoxification treatment of opiate dependent patients European Neuropsychopharmacology. 5: 403. DOI: 10.1016/0924-977X(95)90750-8 |
0.367 |
|
| 1995 |
Schneider C, Fischer G, Diamant K, Pezawas L, Lenzinger E, Presslich O, Kasper S. P-10-3 Morphine-sulphate — an alternative in opiate substitution therapy European Neuropsychopharmacology. 5: 393. DOI: 10.1016/0924-977X(95)90722-P |
0.35 |
|
| 1995 |
Diamant K, Fischer G, Schneider C, Pezawas L, Lenzinger E, Kasper S. P-10-2 Buprenorphine in the treatment of opiate withdrawal syndrome European Neuropsychopharmacology. 5: 393. DOI: 10.1016/0924-977X(95)90721-O |
0.365 |
|
| Show low-probability matches. |
